Fasnall 是一种选择性 FASN 抑制剂，通过其辅因子结合位点起作用。 Fasnall 在 HER2(+) 乳腺癌的 MMTV-Neu 模型中显示出有效的抗肿瘤活性，尤其是与卡铂联合使用时。

Fasnall is a selective FASN inhibitor that acts through its co-factor binding sites. Fasnall shows potent anti-tumor activity in the MMTV-Neu model of HER2(+) breast cancer, particularly in combination with carboplatin.

929978-58-5

C19H22N4S

338.47

Ethanol:20mg/mL (59.09mM)
DMSO:10mg/mL (29.54 mM)
Powder: -20°C for 3 years
In solvent: -80°C for 2 years